Recurrent Thrush: Why It Keeps Coming Back and What Your Vaginal Microbiome Has to Do With It
- Jul 20
- 9 min read
You know the cycle. The itching starts, you recognise it immediately because you have done this before, you go to the chemist, you get the same cream or tablet, it clears up within a few days, and you go on with your life. Until a few weeks or months later, it happens again.
If you have had this experience more than four times in a year, you are dealing with what is clinically termed recurrent vulvovaginal candidiasis. You have been treated for the yeast infection, repeatedly, without anyone investigating the environment that keeps allowing it to return. And this is what is actually allowing thrush to reoccur - it's why treating the yeast alone rarely solves it long-term. Luckily, there's a lot you can do to help get rid of it for good.
Recurrent thrush is rarely just about the yeast. It is about the environment that keeps allowing it to take hold. And that environment is shaped by your vaginal microbiome, your blood sugar, your immune function, and your hormones.
What Counts as Recurrent Thrush?
Vulvovaginal candidiasis, commonly known as thrush, is caused by an overgrowth of Candida species, most often Candida albicans, in the vaginal environment. A single episode is extremely common and not typically a sign that anything deeper is wrong.
Recurrent vulvovaginal candidiasis, or RVVC, is defined as four or more symptomatic episodes within a twelve month period, and it affects an estimated five to ten percent of women. This is the threshold at which it's important to ask why this keep happening, rather than just taking another course of antifungal medication.
The Vaginal Microbiome: Why the Environment Matters More Than the Yeast
Candida is not inherently foreign to the vaginal environment. It exists as part of the normal mucosal flora in many healthy women without causing any symptoms at all. The presence of Candida is not the problem. The overgrowth of Candida, and the inflammatory response it triggers, is what produces symptoms.
What determines whether Candida stays in balance or overgrows is, to a significant degree, the health of the vaginal microbiome. In a protective vaginal environment, Lactobacillus species dominate. These bacteria maintain an acidic vaginal pH, produce hydrogen peroxide and other antimicrobial compounds, and physically compete with Candida and other organisms for space and resources, preventing overgrowth.
A 2023 review published in Frontiers in Cellular and Infection Microbiology confirmed that Lactobacillus species help maintain vaginal homeostasis through acidification of the vaginal microenvironment and production of antifungal metabolites including organic acids, hydrogen peroxide, and bacteriocins. When this protective Lactobacillus dominance is disrupted, the vaginal environment becomes significantly more permissive to Candida overgrowth.
This is why antifungal treatment alone is often a temporary fix rather than a resolution. Antifungal medications clear the active overgrowth of the yeast, but if the underlying vaginal microbiome remains depleted of protective Lactobacillus, the environment that allowed the overgrowth in the first place is still in place. Recolonisation by Candida, or another opportunistic organism, becomes more likely.
Blood Sugar and Insulin Resistance
One of the most well-established and significant risk factors for recurrent thrush is impaired blood sugar regulation. Candida feeds on glucose, and elevated blood sugar, whether from diagnosed diabetes, undiagnosed insulin resistance, or simply suboptimal glucose control, creates conditions that directly favour Candida overgrowth.
A study published in PMC examining predisposing factors to recurrent vulvovaginal candidiasis found that diabetes mellitus and insulin resistance, measured via the HOMA index, were significantly more common in women with positive Candida cultures, including those with recurrent presentations, compared to women without Candida overgrowth. The American Diabetes Association has separately confirmed that diabetes substantially increases the risk of vulvovaginal candidiasis, particularly when blood glucose is inadequately controlled, with the risk profile differing somewhat between type 1 and type 2 diabetes.
This connection matters even for women who do not have a diabetes diagnosis. Subclinical insulin resistance, the kind that exists well before blood glucose rises high enough to meet diagnostic thresholds, can still elevate glucose availability in vaginal secretions enough to favour Candida overgrowth. This is one of the most overlooked and most addressable drivers of recurrent thrush.
Oestrogen and Hormonal Contraceptives
Oestrogen has a well-documented relationship with Candida overgrowth. Elevated oestrogen, whether from pregnancy, high-oestrogen oral contraceptives, or hormone replacement therapy, increases glycogen deposition in the vaginal epithelium. Candida uses this glycogen as a food source and also has oestrogen receptors that appear to directly enhance its ability to adhere to and colonise vaginal tissue.
This is why recurrent thrush is more common during pregnancy, in women using high-oestrogen contraceptive pills, and in women on hormone replacement therapy. It is also relevant for women using vaginal oestrogen for genitourinary symptoms of menopause, where local oestrogen exposure can similarly favour Candida overgrowth in susceptible individuals.
This does not mean these treatments need to be avoided. It means that for women experiencing recurrent thrush alongside hormonal contraceptive or hormone therapy use, the hormonal contribution is worth acknowledging and managing alongside other strategies, rather than treating each thrush episode as an isolated event.
The Immune System
Recurrent thrush is increasingly understood to involve a distinct immune signature, not simply repeated exposure to the same trigger.
Research published in PMC found that women with recurrent vulvovaginal candidiasis show a distinct immune response compared to women with single episodes, with significantly lower levels of inflammatory markers including IFN-gamma, TNF-alpha, and IL-17F, alongside elevated levels of IL-4, IL-6, and IL-10. This altered immune signalling pattern appears to impair the ability to fully clear Candida and may explain why some women experience repeated episodes while others with similar exposure do not.
Chronic stress is directly relevant to this picture. Stress hormones modulate immune function, and a dysregulated stress response has been specifically implicated in recurrent thrush susceptibility. Studies have confirmed that women with recurrent vulvovaginal candidiasis had lower early-morning cortisol levels and lower antioxidant capacity than women without the condition.
This means that addressing recurrent thrush purely as a localised vaginal issue, without considering immune function and the body's stress response more broadly, misses a meaningful part of the picture for many women.
“When a woman comes to me with recurrent thrush, I am never just thinking about the infection. I am thinking about her vaginal microbiome, whether her blood sugar regulation has ever actually been assessed, what her gut health looks like, what hormonal contraceptives or treatments she might be using, and what her overall immune and stress look like. Treating thrush without addressing the environment it is thriving in is why so many women end up on repeated rounds of antifungals with no lasting resolution. When we address the bigger picture, recurrence rates improve significantly.”
- Gemma Knaap, Naturopath (BHSc Naturopathy, Certified Natural Fertility Educator, Gut Microbiome Analyst) | Southernwood Apothecary & Clinic
The Gut-Vaginal Microbiome Connection
The gut and vaginal microbiomes are not isolated from each other. There is a documented relationship between gut dysbiosis and vaginal dysbiosis, and several proposed mechanisms for why one affects the other.
Some researchers have identified the gut as a reservoir for vaginal recolonisation, meaning that even after successful local antifungal treatment, Candida present in the gastrointestinal tract can recolonise the vagina, contributing to recurrence. Diet is also relevant here. A study examining new risk factors for vulvovaginal candidiasis found statistically significant correlations between Candida infection and dietary factors and gut transit time, pointing to gut health as a relevant and modifiable risk factor that is rarely addressed in standard thrush management.
This is also where antibiotic use becomes particularly relevant. Antibiotics disrupt both gut and vaginal Lactobacillus populations, which is why thrush so commonly follows a course of antibiotics for an unrelated infection. If gut Lactobacillus populations are not adequately restored after antibiotic use, the depleted gut environment may continue to influence vaginal microbiome recovery long after the antibiotic course has finished.
Why Antifungal Treatment Alone Often Is Not Enough
None of this is an argument against antifungal treatment. For an active, symptomatic episode of thrush, appropriate antifungal treatment is often the right first step.
The issue is what happens after the active infection clears. If the underlying vaginal microbiome remains Lactobacillus-depleted, if blood sugar regulation has never been assessed, if hormonal or medication related factors are contributing, if gut health has never been addressed, and if the broader immune landscape has not been considered, the conditions that allowed the original overgrowth remain firmly in place. Recurrence under these conditions is not surprising. It is expected.
This is why a thorough approach to recurrent thrush looks different from repeated rounds of the same treatment. It involves identifying which of the contributing factors are relevant for the individual woman and addressing them directly.
What a Comprehensive Approach Looks Like
• Vaginal microbiome testing & support: targeted probiotic strategies, alongside avoiding unnecessary disruption to the vaginal ecosystem.
• Blood sugar assessment and support: investigating glucose regulation and insulin sensitivity even in the absence of a diabetes diagnosis, and addressing this through diet and lifestyle where relevant.
• Gut health: addressing gut dysbiosis and supporting the gut-vaginal microbiome relationship through diet and targeted probiotic support.
• Hormonal review: considering whether hormonal imbalances or medications are contributing and discussing this alongside other strategies.
• Immune and stress support: addressing the broader immune and nervous system environment.
• Reviewing antibiotic history: and ensuring adequate gut and vaginal microbiome restoration after any antibiotic course.
You Deserve More Than Another Prescription
If you have had recurrent thrush for months or years and the only conversation you have ever had is which antifungal to use next, it's time to consider the broader context behind the infection. Recurrent thrush is a signal that something in your vaginal, gut, hormonal, or immune environment needs proper attention, not just repeated short-term symptom relief.
You deserve a practitioner who will look at the bigger picture and help you understand what is actually driving the recurrence in your individual circumstances, so that you can move from managing it indefinitely to actually resolving it.
In person consultations are available at my Albany clinic and Telehealth consultations are available from anywhere in Australia.
Frequently Asked Questions
What counts as recurrent thrush?
Recurrent vulvovaginal candidiasis is defined as four or more symptomatic episodes of thrush within a twelve month period. It affects an estimated five to ten percent of women and warrants investigation into the underlying drivers rather than ongoing treatment of individual episodes in isolation.
Why does thrush keep coming back even after treatment?
Antifungal treatment addresses the active Candida overgrowth but does not necessarily address the underlying vaginal microbiome environment that allowed the overgrowth to occur. If protective Lactobacillus populations remain depleted, if blood sugar regulation is impaired, if hormonal factors are contributing, or if gut health is compromised, the conditions that led to the original infection remain in place, making recurrence likely regardless of how effectively each individual episode is treated.
Is there a connection between blood sugar and recurrent thrush?
Yes. Candida feeds on glucose, and elevated blood sugar from diabetes or insulin resistance creates conditions that favour Candida overgrowth. Research has found that diabetes mellitus and insulin resistance, measured via the HOMA index, are significantly more common in women with recurrent vulvovaginal candidiasis than in women without the condition. This connection is relevant even for women without a formal diabetes diagnosis, as subclinical insulin resistance can still elevate glucose availability enough to favour Candida overgrowth.
Can hormonal contraceptives or HRT cause recurrent thrush?
High-oestrogen oral contraceptives, hormone replacement therapy, and pregnancy are all recognised risk factors for vulvovaginal candidiasis. Elevated oestrogen increases glycogen deposition in the vaginal epithelium, which Candida uses as a food source, and oestrogen receptors on Candida appear to enhance its ability to colonise vaginal tissue. This does not mean hormonal treatments need to be discontinued, but the contribution is worth discussing with a practitioner who can help manage the vaginal microbiome alongside continued hormone use if needed.
What is the connection between gut health and recurrent thrush?
The gut and vaginal microbiomes interact, and gut dysbiosis is increasingly recognised as a contributing factor to recurrent vaginal Candida overgrowth. Dietary factors, gut transit time, and antibiotic history, which disrupts both gut and vaginal Lactobacillus populations, are all relevant to this connection.
Can probiotics help with recurrent thrush?
Research on probiotics for vulvovaginal candidiasis specifically is less robust than for bacterial vaginosis, but emerging evidence supports the use of specific Lactobacillus strains, including Lactobacillus species shown to inhibit Candida growth and biofilm formation, as part of a comprehensive approach. Combining probiotic support with antifungal treatment may help reduce the microbiota disruption caused by antifungal medications and support a more resilient vaginal environment going forward. Strain selection matters, and professional guidance on appropriate products is recommended.
Can a naturopath help with recurrent thrush?
Yes. A naturopath investigates the bigger picture contributing to recurrent thrush, including vaginal and gut microbiome health, blood sugar regulation, hormonal factors, and immune and nervous system function. This comprehensive approach addresses the underlying environment that allows Candida to overgrow repeatedly, rather than only treating each individual episode. This work complements appropriate antifungal treatment for active infections.
About the Author
Gemma Knaap is a naturopath specialising in women's hormonal health, gut health, fertility, and reproductive wellbeing. She holds a Bachelor of Health Science in Naturopathy and is a Certified Natural Fertility Educator and Gut Microbiome Analyst. In person consultations are available at her Albany, WA clinic. Telehealth consultations are available across Australia. Book online here.
References
Sun, et al. (2023). Vulvovaginal candidiasis and vaginal microflora interaction: Microflora changes and probiotic therapy. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1123026
Frontiers in Microbiology. (2025). New insights toward personalized therapies for vulvovaginal candidiasis and vaginal co-infections. https://doi.org/10.3389/fmicb.2025.1625952
PMC. (2016). Highlights Regarding Host Predisposing Factors to Recurrent Vulvovaginal Candidiasis: Chronic Stress and Reduced Antioxidant Capacity. https://pmc.ncbi.nlm.nih.gov/articles/PMC4944939/
American Diabetes Association. (2023). Diabetes and Vulvovaginal Conditions. Clinical Diabetes, 41(3), 458. https://diabetesjournals.org/clinical/article/41/3/458/148660
PMC. (2022). Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366074/
PMC. (2019). Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441174/
PMC. (2021). Vulvovaginal candidiasis and current perspectives: new risk factors and laboratory diagnosis by using MALDI TOF. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295079/
Survey of incidence, lifetime prevalence, and treatment of self-reported vulvovaginal candidiasis, United States, 2020. PMC. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092842/
ASM.org. (2025). Can Probiotics Transform the Vaginal Microbiome? https://asm.org/articles/2025/april/can-probiotics-transform-vaginal-microbiome
Comments